NYSE · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · MID CAP
Auna S.a. AUNA
3 fiscal years on record · PEN · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
PEN 4.4B
▲ 13.2% vs FY2023
EPS · FY24
PEN 1.63
Dividend / sh · FY24
—
Payout · FY24
1%
ROE · FY24
7.5%
Net margin · FY24
2.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
PEN 4.4B
Revenue, FY2024 · full 3-year series below
Revenue
Net income
3 cents of every revenue dollar became profit this year.
Per share
PEN 1.63
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
7.5%
Return on equity, FY2024
ROE
Operating margin17.9%
Net margin2.5%
Return on assets1.5%
Each PEN of equity produced 7 cents of profit this year.
Returned to shareholders
PEN 1.1M
returned in FY2024 · dividends + net buybacks
Dividends paidPEN 1.1M
Net buybacks—
Share of profit1.0%
Consecutive raises—
PEN 1.1M in dividends — 1% of the year's profit went back to shareholders.
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2024
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
PEN 7.1B
total assets, end of FY2024
Total assetsPEN 7.1B
EquityPEN 1.5B
CashPEN 235.7M
Gross debtPEN 3.6B
Net debtPEN 3.4B
Current ratio0.88×
Net debt stands at 229% of equity.
History
3 fiscal years
Every figure from documents filed with the SEC · PEN
Metric
2024
2023
2022
Revenue PEN B
4.4
3.9
2.5
Operating income PEN B
0.8
0.6
0.3
EBITDA PEN B
1.0
0.8
0.4
Income tax PEN B
0.1
0.1
0.0
Net income PEN B
0.1
−0.3
−0.1
EPS, diluted PEN
1.63
−5.78
−1.95
Dividend / sh PEN
·
·
·
Payout %
1
−3
−0
ROE %
7.5
−20.1
−8.0
Shares out B
0.07
0.04
0.04
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
12 of 12
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed